Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Index
-
Market Cap
12.49B
Enterprise Value
16.05B
Income
-242.00M
Sales
4.89B
Book/sh
13.02
Cash/sh
0.86
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9900
IPO
Sep 20, 2018
P/E
-
Forward P/E
20.97
PEG
1.60
P/S
2.55
P/B
1.92
P/C
29.17
P/FCF
39.64
EV/EBITDA
16.19
EV/Sales
3.28
Quick Ratio
1.12
Current Ratio
2.16
Debt/Eq
0.61
LT Debt/Eq
0.60
Option/Short
Yes / Yes
EPS (ttm)
-0.49
EPS next Y
1.19
EPS next Q
0.27
EPS this Y
13.30%
EPS next Y
11.91%
EPS next 5Y
13.14%
EPS past 3/5Y
-43.04% 18.11%
Sales past 3/5Y
2.25% 7.57%
EPS Y/Y TTM
-164.58%
Sales Y/Y TTM
10.53%
EPS Q/Q
-16.78%
Sales Q/Q
14.92%
Insider Own
1.03%
Insider Trans
0.19%
Inst Own
109.86%
Inst Trans
0.96%
ROA
-1.85%
ROE
-3.77%
ROIC
-2.32%
Gross Margin
43.76%
Oper. Margin
6.13%
Profit Margin
-4.95%
SMA20
3.70%
SMA50
8.10%
SMA200
9.25%
Trades
Shs Outstand
499.38M
Shs Float
494.40M
52W High
27.72 -9.81%
52W Low
13.39 86.71%
Volatility
4.09% 4.22%
ATR (14)
1.01
RSI (14)
58.00
Beta
1.68
Rel Volume
0.98
Avg Volume
5.78M
Volume
5,689,171
Perf Week
2.59%
Perf Month
5.80%
Perf Quarter
8.13%
Perf Half Y
9.84%
Perf YTD
10.47%
Perf Year
69.84%
Perf 3Y
148.51%
Perf 5Y
-28.45%
Perf 10Y
-
Prev Close
24.09
Price
25.00
Change
3.78%
Date Action Analyst Rating Change Price Target Change
Apr-15-26Initiated Citigroup Buy $30
Jan-22-26Upgrade Piper Sandler Neutral → Overweight
Dec-09-25Initiated Barclays Overweight $30
Nov-21-25Initiated KeyBanc Capital Markets Overweight $27
Nov-19-25Upgrade Argus Hold → Buy $25
Oct-07-25Upgrade JP Morgan Neutral → Overweight $24
Jul-17-25Upgrade Leerink Partners Market Perform → Outperform $18
Jun-26-25Upgrade William Blair Mkt Perform → Outperform
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Jun-18-26 07:26AM
Jun-15-26 08:47AM
Jun-04-26 01:47PM
10:23AM
06:26AM
07:26AM Loading…
Jun-03-26 07:26AM
May-18-26 07:27AM
May-14-26 08:00AM
May-06-26 12:51PM
08:12AM
06:27AM
Apr-27-26 06:23PM
Apr-16-26 08:00AM
Apr-15-26 09:47AM
Apr-13-26 04:08PM
08:27AM Loading…
Apr-09-26 08:27AM
Mar-23-26 01:38PM
Mar-16-26 03:23PM
Feb-26-26 09:56AM
Feb-24-26 04:22PM
03:08PM
02:01PM
12:32PM
11:25AM
09:30AM
08:15AM
06:38AM
06:27AM
Feb-23-26 10:57AM
Feb-22-26 10:06PM
09:15AM Loading…
Feb-19-26 09:15AM
08:00AM
Feb-13-26 09:24AM
Feb-10-26 06:41AM
Jan-30-26 11:56AM
Jan-28-26 07:50AM
Jan-27-26 04:04PM
Jan-26-26 11:35PM
Jan-22-26 04:36PM
08:00AM
06:00AM
Jan-12-26 06:54PM
Jan-06-26 11:08PM
06:52PM
08:00AM
Dec-31-25 02:00PM
Dec-21-25 10:07AM
Dec-19-25 01:30AM
Dec-18-25 08:43AM
Dec-16-25 02:05PM
09:40AM
Dec-12-25 12:00PM
Dec-09-25 04:15PM
07:40AM
Nov-24-25 07:00PM
Nov-21-25 01:35PM
Nov-20-25 08:00AM
Nov-14-25 09:03AM
Nov-13-25 08:00AM
Nov-12-25 12:35AM
Nov-11-25 08:46AM
Nov-06-25 12:33AM
Nov-05-25 07:26PM
03:12PM
02:01PM
09:30AM
07:35AM
06:36AM
06:27AM
Nov-03-25 10:19PM
04:28PM
Oct-29-25 10:00AM
Oct-28-25 11:27AM
Oct-27-25 06:27AM
Oct-24-25 05:33PM
04:55PM
12:02AM
Oct-23-25 11:40AM
Oct-22-25 09:40AM
Oct-20-25 02:03PM
Oct-17-25 06:39PM
Oct-16-25 04:32PM
Oct-08-25 12:00PM
Oct-07-25 11:31AM
Oct-06-25 11:40AM
05:15AM
Oct-01-25 08:00AM
Sep-30-25 12:00PM
Sep-24-25 12:01PM
Sep-23-25 07:10PM
06:27AM
Sep-11-25 10:57PM
Sep-08-25 03:35PM
06:27AM
Sep-03-25 02:45PM
Sep-01-25 11:31PM
Aug-27-25 12:31PM
08:00AM
Aug-26-25 06:15PM
08:00AM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
PresidentMr. Jeffrey N. Simmons
Executive VP & CFOMr. Robert M. VanHimbergen
Executive VP & President of Elanco InternationalDr. Ramiro Martin Cabral
Executive Vice President of ResearchDr. Ellen de Brabander Ph.D.
Executive Vice President of Center of Strategic GrowthMr. Timothy J. Bettington
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Modi Rajeev A.SEE REMARKSMay 15 '26Buy20.354,91199,939160,812May 19 04:39 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORMay 15 '26Buy20.094,97199,843171,971May 19 04:38 PM
Kurzius Lawrence ErikDirectorDec 12 '25Buy21.3010,000213,000131,773Dec 16 04:42 PM
Modi Rajeev A.SEE REMARKSDec 11 '25Buy21.334,50095,985123,082Dec 15 04:43 PM
VanHimbergen Robert MEVP and CFODec 11 '25Buy21.646,950150,426124,233Dec 15 04:42 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORDec 11 '25Buy21.7522,000478,496167,000Dec 15 04:41 PM
Todd S and Jennifer G Young LiFormer CFOAug 11 '25Proposed Sale16.8249,333830,000Aug 11 03:58 PM